These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 985377)

  • 61. Creatine kinase activity from rat brain is inhibited by branched-chain amino acids in vitro.
    Pilla C; Cardozo RF; Dutra-Filho CS; Wyse AT; Wajner M; Wannmacher CM
    Neurochem Res; 2003 May; 28(5):675-9. PubMed ID: 12716015
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An early diagnosis leads to a good prognosis: a patient with maple syrup urine disease--screened by tandem mass spectrometry.
    Lin JF; Chiu PC; Hsu HY; Lin SM; Chen YY; Hsieh KS
    Acta Paediatr Taiwan; 2004; 45(5):287-9. PubMed ID: 15868812
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Maple syrup urine disease: magnetic resonance imaging findings in three patients.
    Allahwala A; Ahmed S; Afroze B
    J Pak Med Assoc; 2021 Apr; 71(4):1309-1313. PubMed ID: 34125801
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A new variety of maple syrup urine disease.
    Harkness RA; Cockburn F; Grant M; Giles MM; Turner TL; Darling JA
    Ann Clin Biochem; 1977 May; 14(3):146-8. PubMed ID: 869494
    [No Abstract]   [Full Text] [Related]  

  • 65. Complementation of defective leucine decarboxylation in fibroblasts from a maple syrup urine disease patient by retrovirus-mediated gene transfer.
    Mueller GM; McKenzie LR; Homanics GE; Watkins SC; Robbins PD; Paul HS
    Gene Ther; 1995 Sep; 2(7):461-8. PubMed ID: 7584124
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Thiamin-responsive maple-syrup-urine disease: decreased affinity of the mutant branched-chain alpha-keto acid dehydrogenase for alpha-ketoisovalerate and thiamin pyrophosphate.
    Chuang DT; Ku LS; Cox RP
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3300-4. PubMed ID: 6954481
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Maple Syrup Urine Disease in a newborn infant].
    Mazur A; Sykut-Cegielska J; Ciebiera M; Trzeciak J; Taybert J; Kowalik A; Ołtarzewski M
    Med Wieku Rozwoj; 2007; 11(1):65-8. PubMed ID: 17965467
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease.
    Barschak AG; Sitta A; Deon M; de Oliveira MH; Haeser A; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2006 Dec; 21(4):279-86. PubMed ID: 17091400
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of branched-chain amino acid antagonism in the rat on tissue amino acid and keto acid concentrations.
    Shinnick FL; Harper AE
    J Nutr; 1977 May; 107(5):887-95. PubMed ID: 870654
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Metabolism of branched-chain amino acids in maple syrup urine disease.
    Schadewaldt P; Wendel U
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S62-6. PubMed ID: 9266218
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diagnosis of maple syrup urine disease by determination of L-valine, L-isoleucine, L-leucine and L-phenylalanine in neonatal blood spots by gas chromatography-mass spectrometry.
    Deng C; Deng Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(2):261-8. PubMed ID: 12860033
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Glucose and alanine metabolism in children with maple syrup urine disease.
    Haymond MW; Ben-Galim E; Strobel KE
    J Clin Invest; 1978 Aug; 62(2):398-405. PubMed ID: 670400
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Production and characterization of murine models of classic and intermediate maple syrup urine disease.
    Homanics GE; Skvorak K; Ferguson C; Watkins S; Paul HS
    BMC Med Genet; 2006 Mar; 7():33. PubMed ID: 16579849
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Outcomes from a Single Transplant Center of 5 Pediatric Cases of Domino Liver Transplantation from Live Donors with Maple Syrup Urine Disease.
    Zhang JP; Zhu ZJ; Sun LY; Wei L; Qu W; Zeng ZG; Zhang HM; Liu Y
    Ann Transplant; 2023 May; 28():e939893. PubMed ID: 37248682
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Myelin proteins: degradation in rat brain initiated by metabolites causative of maple syrup urine disease.
    Tribble D; Shapira R
    Biochem Biophys Res Commun; 1983 Jul; 114(2):440-6. PubMed ID: 6411085
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Biochemical studies on a variant of branched chain ketoaciduria in a 19-year-old female.
    Fischer MH; Gerritsen T
    Pediatrics; 1971 Nov; 48(5):795-801. PubMed ID: 5125877
    [No Abstract]   [Full Text] [Related]  

  • 77. Quantification of branched-chain amino acids in blood spots and plasma by liquid chromatography tandem mass spectrometry for the diagnosis of maple syrup urine disease.
    Sowell J; Pollard L; Wood T
    J Sep Sci; 2011 Mar; 34(6):631-9. PubMed ID: 21328532
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Successful pregnancy in maple syrup urine disease: a case report and review of the literature.
    Grünert SC; Rosenbaum-Fabian S; Schumann A; Schwab KO; Mingirulli N; Spiekerkoetter U
    Nutr J; 2018 May; 17(1):51. PubMed ID: 29753318
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management.
    Thompson GN; Francis DE; Halliday D
    J Pediatr; 1991 Jul; 119(1 Pt 1):35-41. PubMed ID: 2066856
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intermittent branched chain ketonuria (variant of maple syrup urine disease).
    Irwin WC; Martel SB; Goluboff N
    Clin Biochem; 1971 Jun; 4(2):52-8. PubMed ID: 5128296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.